Table 2.
Multivariable analyses for preoperative risk factors for LNM in HCC patients.
| Factors | No. of Patients (n=673) | OR (95%CI) | P |
|---|---|---|---|
| Gender | 0.183 | ||
| Female | 181 (26.9) | – | |
| Male | 492 (73.1) | – | |
| Race | |||
| Other | 205 (30.5) | Reference | |
| White | 468 (69.5) | 4.841 (1.480-15.836) | 0.009 |
| Tumor Size | |||
| ≤64mm | 520 (77.3) | Reference | |
| >64mm | 153 (22.7) | 4.163 (1.485-11.669) | 0.007 |
| cT Stage | |||
| cT1-2 | 562 (83.5) | Reference | |
| cT3-4 | 111 (16.5) | 3.003 (1.121-8.045) | 0.029 |
| Major Vascular Invasion | 0.594 | ||
| No/Unknown | 637 (94.7) | – | |
| Yes | 36 (5.3) | – | |
| Extrahepatic Bile Duct Invasion† | |||
| No/Unknown | 662 (98.4) | Reference | |
| Yes | 11 (1.6) | 6.638 (1.019-43.239) | 0.048 |
| Grade‡ | |||
| G1-G2 | 431 (64.0) | Reference | |
| G3-G4 | 129 (19.2) | 6.130 (2.293-16.386) | <0.001 |
| Unknown | 113 (16.8) | 1.266 (0.249-6.434) | 0.776 |
LNM, Lymph node metastasis; HCC, Hepatocellular carcinoma; OR, Odds ratio.
†Including gallbladder invasion.
‡G1, Well differentiated; G2=Moderately differentiated; G3, Poorly differentiated; G4, Undifferentiated.